Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 32 out of 100. Risk genes beyond APOE

Topic: Brain proteins, microglia and lab models

Plain-language summary

MDVs are small vesicles that bud from mitochondria and play an important role in removing damaged mitochondrial components. Recent studies have highlighted the importance of MDVs in NDs such as PD and AD. Accordingly, mitochondrial dysfunction, a defining characteristic of NDs, results in an increased production of MDVs which transport damaged proteins to cellular compartments, including peroxisomes and lysosomes, where they are degraded. Furthermore, the release of mitochondrial damage-associated molecular patterns by these vesicles into the extracellular environment leads to the triggering of inflammatory responses, which contribute to neuronal damage. Understanding the mechanisms by which MDVs may influence neurodegeneration may provide new therapeutic targets for these debilitating diseases. Perspective: What has been described so far represents indirect evidence of the correlation between MDVs and NDs. In fact, to the author’s knowledge, there is no work reporting direct contributions of these vesicles. Certainly, the design of targeted and specific work could enrich the understanding of these mechanisms leading to possible therapeutic approaches. For example, in the clinical field, these vesicles could be used as diagnostic or prognostic markers. Attending to the number or composition of these vesicles in biological samples from affected patients and possibly observing them over time could give insight into the mitochondrial status and subsequent neuronal activity in NDs. Moreover, since MDVs act as an early defense mechanism for the mitochondria to remove damaged or aggregated proteins typical of several NDs, they could be considered a promising target to act on. These are all the author’s reflections which would need further investigation that could be promising insights for future studies. This work was supported by project Emerging Infectious Diseases One Health Basic and Translational Research Actions addressing Unmet Needs on Emerging Infectious Diseases, INF- ACT, Spoke 1 and Spoke 5, Project number PE00000007, CUP B53C20040570005 (to PP and DN). C-Editors: Zhao M, Liu WJ, Qiu Y; T-Editor: Jia Y

What this study adds

Evidence grade: Low

This perspective article describes mitochondria-derived vesicles as involved in removing damaged mitochondrial components and notes that their release can trigger inflammatory responses contributing to neuronal damage. The author states there is only indirect evidence and no work reporting direct contributions, so no treatment is established.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Palumbo, L., Nuzzo, D., Girgenti, A., & Picone, P. (2025). Mitochondria-derived vesicles: New players in the game of neurodegeneration. Neural Regeneration Research. https://doi.org/10.4103/nrr.nrr-d-24-01220

Vancouver

Palumbo L, Nuzzo D, Girgenti A, Picone P. Mitochondria-derived vesicles: New players in the game of neurodegeneration. Neural Regeneration Research. 2025. doi:10.4103/nrr.nrr-d-24-01220. PMID: 39819868.

BibTeX

@article{palumbo2025-39819868,
  author  = {Palumbo, Laura and Nuzzo, Domenico and Girgenti, Antonella and Picone, Pasquale},
  title   = {{Mitochondria-derived vesicles: New players in the game of neurodegeneration}},
  journal = {Neural Regeneration Research},
  year    = {2025},
  doi     = {10.4103/nrr.nrr-d-24-01220},
  pmid    = {39819868},
  url     = {https://doi.org/10.4103/nrr.nrr-d-24-01220}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This perspective article describes mitochondria-derived vesicles as involved in removing damaged mitochondrial components and notes that their release can trigger inflammatory responses contributing to neuronal damage. The author states there is only indirect evidence and no work reporting direct contributions, so no treatment is established.

Study details

How this study scored 32/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 1 of 4; Institution's track record 0 of 3; Multicenter collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 32 of 100.32 of 100 points earned68 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Neural Regeneration Research)
Journal's citation record 1 / 4 Neural Regeneration Research: journal h-index 100 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 3 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.0 citations a year over 3 year(s) since 2025
Impact for its field and year 1 / 6 Cited 0.8× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Pasquale Picone: h-index 5 (OpenAlex, whole career)
Institution's track record 0 / 3 Institute for Biomedical Research and Innovation: institution h-index 91 (OpenAlex)
Multicenter collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 39819868)
Free to read 2 / 2 Free to read
Total 32 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Related studies in Risk genes beyond APOE from nearby years

Also tagged “tdp-43”

1,150 studies in the library carry the topic tag “tdp-43”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Risk genes beyond APOE

See all studies in Risk genes beyond APOE →